MedTrace Logo

COVID-19 and Childhood Cancer

NCT06482281 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-07-03

No results posted yet for this study

Summary

The investigators will first examine the impact of the COVID-19 pandemic on childhood cancer patients in Sweden and Denmark, both regarding susceptibility to severe COVID-19 among long-term childhood cancer survivors, and, for those diagnosed with childhood cancer during the pandemic, whether the path through primary care to cancer diagnosis as well as short-term survival has changed. Second, the investigators will study childhood cancer incidence before, during and after the pandemic with the particular aim to test the hypothesis regarding an infectious disease etiology for acute lymphoblastic leukemia.

Conditions

  • COVID-19
  • Childhood Cancer
  • Childhood Leukemia, Acute Lymphoblastic

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV

  • The Swedish Childhood Cancer Fund

    collaborator UNKNOWN

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Giorgio Tettamanti, PhD · Karolinska Institutet

Eligibility

Min Age
0 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482281 on ClinicalTrials.gov